Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.33 |
| ▸ | RELA | Q04206 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.31 |
| ▸ | SLC16A1 | P53985 | 1/20 | 0.31 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.30 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13680252 | 1.00 | APP (0.33) | APPRELAALDH1A1MAPTMAPK1 | |
| SCHEMBL13680273 | 1.00 | APP (0.33) | APPRELAALDH1A1MAPTMAPK1 | |
| SCHEMBL990255 | 1.00 | APP (0.33) | APPRELAALDH1A1MAPTMAPK1 | |
| SCHEMBL13680271 | 0.95 | CA1 (0.32) | RELAALDH1A1MAPTMAPK1RAB9A | |
| SCHEMBL13680263 | 0.93 | APP (0.35) | APPALDH1A1MAPTMAPK1RAB9A | |
| SCHEMBL13680272 | 0.93 | MAPT (0.33) | APPMAPT | |
| SCHEMBL12402695 | 0.91 | MAPT (0.32) | RELAALDH1A1MAPTMAPK1L3MBTL1 | |
| SCHEMBL13680274 | 0.91 | PTGS1 (0.34) | — | |
| SCHEMBL13680259 | 0.90 | RELA (0.32) | RELAALDH1A1MAPT | |
| SCHEMBL13680267 | 0.89 | RELA (0.35) | APPRELAALDH1A1MAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8518559-B2 | Arylamine compounds and electronic devices | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2013-08-27 | — | — | US | claimed |
| US-20100133519-A1 | ARYLAMINE COMPOUNDS AND ELECTRONIC DEVICES | AGENCY FOR SCIENCE, TECHNOLOGY ANR RESEARCH | 2010-06-03 | — | — | US | claimed |
| EP-2121573-A1 | ARYLAMINE COMPOUNDS AND ELECTRONIC DEVICES | Agency for Science Technology and Research (SG) | 2009-11-25 | — | — | EP | claimed |
| WO-2008069756-A1 | ARYLAMINE COMPOUNDS AND ELECTRONIC DEVICES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2008-06-12 | — | — | WO | claimed |
| US-8933319-B2 | Photoelectric conversion element and imaging device | FUJIFILM CORPORATION (JP) | 2015-01-13 | — | — | US | disclosed |
| CN-101573324-B | Arylamine compounds and electronic devices | AGENCY SCIENCE TECH & RES | 2013-11-20 | — | — | CN | disclosed |
| US-8518559-B2 | Arylamine compounds and electronic devices | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2013-08-27 | — | — | US | disclosed |
| WO-2011008168-A1 | ORGANIC LIGHT EMITTING MATERIALS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-01-20 | — | — | WO | disclosed |
| WO-2011008169-A1 | ORGANIC AMBIPOLAR LIGHT EMITTING MATERIALS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-01-20 | — | — | WO | disclosed |
| US-20100133519-A1 | ARYLAMINE COMPOUNDS AND ELECTRONIC DEVICES | AGENCY FOR SCIENCE, TECHNOLOGY ANR RESEARCH | 2010-06-03 | — | — | US | disclosed |
| EP-2121573-A1 | ARYLAMINE COMPOUNDS AND ELECTRONIC DEVICES | Agency for Science Technology and Research (SG) | 2009-11-25 | — | — | EP | disclosed |
| CN-101573324-A | Arylamine compounds and electronic devices | AGENCY SCIENCE TECH & RES (SG) | 2009-11-04 | — | — | CN | disclosed |
| WO-2008069756-A1 | ARYLAMINE COMPOUNDS AND ELECTRONIC DEVICES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2008-06-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100133519-A1 | ARYLAMINE COMPOUNDS AND ELECTRONIC DEVICES | TYR, AHR, ARNT | APP 1473/4885RELA 2453/4885ALDH1A1 868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.